PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 44 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $164,000 | -2.4% | 23,303 | -2.5% | 0.09% | +335.0% |
| Q4 2019 | $168,000 | +33.3% | 23,900 | +136.6% | 0.02% | +233.3% |
| Q1 2019 | $126,000 | -80.2% | 10,100 | -89.3% | 0.01% | -86.4% |
| Q4 2018 | $636,000 | -55.5% | 94,600 | -31.8% | 0.04% | -46.3% |
| Q3 2018 | $1,428,000 | +53.7% | 138,800 | +0.4% | 0.08% | +51.9% |
| Q2 2018 | $929,000 | +32.5% | 138,300 | +69.3% | 0.05% | +20.0% |
| Q1 2018 | $701,000 | +56.8% | 81,700 | +280.0% | 0.04% | +87.5% |
| Q4 2017 | $447,000 | +10.9% | 21,500 | -31.7% | 0.02% | -4.0% |
| Q1 2017 | $403,000 | -41.8% | 31,500 | 0.0% | 0.02% | -56.1% |
| Q4 2016 | $692,000 | -22.2% | 31,500 | -25.2% | 0.06% | -20.8% |
| Q3 2016 | $889,000 | – | 42,100 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |